Month: February 2014

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 25, 2014 – Industry Standard Research (ISR) has announced the availability of a new report titled “Forest Labs Clinical Development Profile.”  This report provides a thorough analysis of Forest Laboratories’ R&D pipeline, clinical trial activity, patents, FDA submissions, and includes profiles of Forest’s … Continued

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 20, 2014 – Industry Standard Research (ISR) released a new market research report this week entitled “Brazil: Clinical Development Country Profile.” The report provides insight into the clinical trial environment in Brazil, sponsor and service provider activities in the region, as well as the Brazilian … Continued

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 19, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Brain Cancer (Glioblastoma Multiforme): Disease and Pipeline Analysis,” offering the biopharmaceutical industry an in-depth overview of the current glioblastoma multiforme (GBM) market and an analysis … Continued

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 4, 2014 – Industry Standard Research (ISR) has announced the availability of a new report titled “2014 CRO Market Size Projections: 2012-2018.”  For this report, ISR has utilized both publically available information and data obtained through their syndicated primary market research to provide … Continued